Division of Neonatology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN, USA.
Children's Minnesota, Minneapolis, MN, USA.
J Perinatol. 2024 Nov;44(11):1617-1623. doi: 10.1038/s41372-024-01933-3. Epub 2024 Apr 1.
To investigate the relationship between insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3) and long-term growth, body composition, and neurodevelopment in preterm infants.
Prospective data were collected from ≤32 weeks gestational age infant cohort (N = 50). IGF-1 and IGFBP-3 concentrations were measured at 1 week (early) and 35 weeks (late) post-menstrual age (PMA). Growth, body composition, and neurodevelopment outcomes were measured at 4 and 12 months PMA. Relationships were measured by linear regression analysis.
Early IGFBP-3 concentration was positively associated with neurodevelopment at 12 months PMA. Early IGF-1 concentration was positively associated with weight at 4 months PMA, head circumference at 12 months PMA, and body mass index at 12 months PMA. Late IGFBP-3 concentration was positively associated with weight at 4 months PMA.
Further investigation of these associations may lead to novel biomarkers and/or treatments to optimize health outcomes in preterm infants.
研究胰岛素样生长因子 1(IGF-1)、胰岛素样生长因子结合蛋白 3(IGFBP-3)与早产儿长期生长、身体成分和神经发育的关系。
从≤32 周胎龄婴儿队列(N=50)中收集前瞻性数据。在胎龄 1 周(早期)和 35 周(晚期)时测量 IGF-1 和 IGFBP-3 浓度。在胎龄 4 个月和 12 个月时测量生长、身体成分和神经发育结果。通过线性回归分析测量相关性。
早期 IGFBP-3 浓度与 12 个月胎龄时的神经发育呈正相关。早期 IGF-1 浓度与 4 个月胎龄时的体重、12 个月胎龄时的头围和 12 个月胎龄时的体重指数呈正相关。晚期 IGFBP-3 浓度与 4 个月胎龄时的体重呈正相关。
进一步研究这些相关性可能会导致新的生物标志物和/或治疗方法,以优化早产儿的健康结果。